MARY MCGOWAN: Open Payments
NPI 1093757999 · SOUTH SIOUX CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 21 payments from 8 companies in 2025. Trend: 2023 $278 · 2024 $389 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $210 |
| Amgen Inc. | 2 | $159 |
| ACADIA Pharmaceuticals Inc | 1 | $109 |
| Insulet Corporation | 1 | $45 |
| ViiV Healthcare Company | 1 | $40 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: Ozempic, EVENITY, NUPLAZID, KRYSTEXXA, OMNIPOD, Wegovy, DOVATO, VAXELIS.
Industry payments across NE — which companies pay providers there.
